US 9,249,149 K1 (3,546th)
	Deuterated derivatives of ruxolitinib
I. Robert Silverman; Julie F. Liu; Adam J. Morgan; Bhaumik Pandya; and Scott L. Harbeson
Assigned to SUN PHARMACEUTECALS INDUSTRIES, INC.
Trial No. IPR2017-01256, Apr. 7, 2017
Inter Partes Review Certificate for Patent 9,249,149, issued Feb. 2, 2016, Appl. No. 14/707,912, May 8, 2015
Inter Partes Review Certificate issued Apr. 2, 2024